4-Fluoro-2-methoxy-1-nitrobenzene (CAS 448-19-1)
QUICK LINKS
4-Fluoro-2-methoxy-1-nitrobenzene is a chemical compound that functions as an intermediate in organic synthesis. It participates in various reactions to form more complex organic compounds, serving as a building block for the creation of new molecules. Its mechanism of action involves undergoing substitution reactions, where the fluorine and nitro groups can be replaced with other functional groups to introduce specific chemical properties into the resulting compounds. 4-Fluoro-2-Methoxy-1-Nitrobenzene′s role in the experimental lies in its ability to facilitate the synthesis of diverse organic molecules with tailored structures and properties. By participating in substitution reactions, it enables the modification of molecular structures to achieve desired characteristics for further development purposes. Its mechanism of action at the molecular level involves the manipulation of specific chemical bonds to create new compounds with potential applications in various fields of study.
4-Fluoro-2-methoxy-1-nitrobenzene (CAS 448-19-1) References
- Development of improved PPARβ/δ inhibitors. | Toth, PM., et al. 2012. ChemMedChem. 7: 159-70. PMID: 22025402
- Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). | Ward, RA., et al. 2013. J Med Chem. 56: 7025-48. PMID: 23930994
- Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance. | Patel, H., et al. 2017. Eur J Med Chem. 142: 32-47. PMID: 28526474
- Pyrimidine containing epidermal growth factor receptor kinase inhibitors: Synthesis and biological evaluation. | Joshi, G., et al. 2017. Chem Biol Drug Des. 90: 995-1006. PMID: 28544624
- Design, synthesis and activity of Mnk1 and Mnk2 selective inhibitors containing thieno[2,3-d]pyrimidine scaffold. | Jin, X., et al. 2019. Eur J Med Chem. 162: 735-751. PMID: 30496989
- Design, synthesis and biological evaluation of 2-arylaminopyrimidine derivatives bearing 1,3,8-triazaspiro[4,5]decan-4-one or piperidine-3-carboxamide moiety as novel Type-I1/2 ALK inhibitors. | Miao, X., et al. 2020. Bioorg Chem. 94: 103456. PMID: 31787343
- Pyrroformyl-containing 2,4-diaminopyrimidine derivatives as a new optimization strategy of ALK inhibitors combating mutations. | Cao, M., et al. 2020. Bioorg Med Chem. 28: 115715. PMID: 33069079
- Investigation into the Formation of Impurities during the Optimization of Brigatinib. | Guo, A., et al. 2020. ACS Omega. 5: 29265-29271. PMID: 33225157
- Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer. | Yang, H., et al. 2021. Eur J Med Chem. 210: 113080. PMID: 33310286
- Structure-based optimization identified novel furyl-containing 2,4-diarylaminopyrimidine analogues as ALK/ROS1 dual inhibitors with anti-mutation effects. | Guo, M., et al. 2021. Eur J Med Chem. 214: 113259. PMID: 33581554
- The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015-2020. | Liang, X., et al. 2021. Bioorg Chem. 113: 105011. PMID: 34091289
- Structure-based design of 2,4-diaminopyrimidine derivatives bearing a pyrrolyl group as ALK and ROS1 inhibitors† | Jie Wang,a Shangfei Wei,a Tong Li,a Lingyun Xing,a Meng Cao,a Nan Jiang,a Ming Guo,a Daiying Zuo ORCID logo *b and Xin Zhai ORCID logo *a. 2020. New J. Chem.,.,44,: 5850-5861.
- Synthesis and properties of new aromatic polyimides containing spirocyclic structures | CA Terraza, LH Tagle, JL Santiago-García… - Polymer, 2018 - Elsevier. 14 February 2018,. Polymer. Volume 137,: Pages 283-292.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-Fluoro-2-methoxy-1-nitrobenzene, 5 g | sc-261920 | 5 g | $50.00 | |||
4-Fluoro-2-methoxy-1-nitrobenzene, 25 g | sc-261920A | 25 g | $146.00 |